Sanara MedTech (SMTI) Net Cash Flow (2010 - 2026)

Sanara MedTech's Net Cash Flow history runs 16 years deep, the most recent figure standing at -$3.0 million for Q1 2026.

• Quarterly Net Cash Flow fell 162.05% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.1 million (down 139.72% YoY) and the FY2025 annual result came in at $700562.0, down 93.47% from the prior year.
• Net Cash Flow was -$3.0 million for Q1 2026 at Sanara MedTech, down from $1.6 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $10.1 million in Q3 2024 and bottomed at -$3.7 million in Q2 2025.
• A 5-year average of -$297551.9 and a median of -$1.3 million in 2022 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2024 — Net Cash Flow surged 5664.22% — and 2025, when it plunged 212.25%.
• Sanara MedTech's Net Cash Flow stood at -$1.3 million in 2022, then grew by 17.92% to -$1.1 million in 2023, then jumped by 63.36% to -$398894.0 in 2024, then soared by 510.94% to $1.6 million in 2025, then slumped by 282.06% to -$3.0 million in 2026.
• Business Quant data shows SMTI's Net Cash Flow at -$3.0 million in Q1 2026, $1.6 million in Q4 2025, and -$2.0 million in Q3 2025.